BTVPUR AlSap 1 Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

btvpur alsap 1

merial - bluetongue-virus serotype-1 antigen - immunologicals - sheep; cattle - active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.onset of immunity has been demonstrated three weeks after the primary vaccination course. the duration of immunity for cattle and sheep is one year after the primary vaccination course.

Bluevac BTV (previously known as Bluevac BTV8) Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

bluevac btv (previously known as bluevac btv8)

cz veterinaria s.a. - bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated] - immunologicals - sheep, cattle - sheepactive immunisation against bluetongue virus serotype 8 to prevent viraemia and to reduce clinical signs.onset of immunity: 20 days after second dose.duration of immunity: 1 year after second dose.cattleactive immunisation against bluetongue virus serotype 8 to prevent viraemia.onset of immunity: 31 days after second dose.duration of immunity: 1 year after second dose.

Bovilis BTV8 Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

bovilis btv8

intervet international bv - bluetongue virus vaccine, serotype 8 (inactivated) - inactivated viral vaccines, bluetongue virus, sheep - sheep; cattle - cattle to stimulate active immunity in sheep from 6 weeks of age against bluetongue virus serotype 8 to reduce viraemia sheep to stimulate active immunity in sheep from 1 month of age against bluetongue virus serotype 8 to prevent viraemia,

BTVPUR Alsap 8 Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

btvpur alsap 8

merial - bluetongue virus serotype 8 antigen - immunologicals for ovidae, immunologicals for bovidae - sheep; cattle - active immunisation of sheep and cattle to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.*(below the level of detection by the validated rt-pcr method at 3.14log10 rna copies/ml, indicating no infectious virus transmission).onset of immunity has been demonstrated 3 weeks after the primary vaccination course.the duration of immunity for cattle and sheep is 1 year after the primary vaccination course.the duration of immunity is not yet fully established in cattle or sheep, although interim results of ongoing studies demonstrate that the duration is at least 6 months after the primary vaccination course in sheep.

Bovilis Blue-8 Umoja wa Ulaya - Kiingereza - EMA (European Medicines Agency)

bovilis blue-8

intervet international b.v. - bluetongue virus vaccine, serotype 8 (inactivated) - immunologicals for ovidae - cattle; sheep - sheepfor the active immunisation of sheep from 2.5 months of age to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.cattlefor the active immunisation of cattle from 2.5 months of age to prevent viraemia* caused by bluetongue virus serotype 8.*(cycling value (ct) ≥ 36 by a validated rt-pcr method, indicating no presence of viral genome)

Bluevac-4 inj. susp. s.c. Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bluevac-4 inj. susp. s.c.

cz vaccines s.a.u. - bluetongue virus serotype 4 (inactivated) - suspension for injection - blue tongue virus serotype 4, inactivated - bluetongue virus; qi04aa02 bluetongue virus - sheep; cattle

TRIVACTON 6 Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

trivacton 6

merial animal health limited - inactivated bovine coronavirus strain f15, inactivated bovine rotavirus strain ro1, inactivated e.coli k99 strain serotype o101, inactivated e.coli y strain serotype o117, inactivated e.coli f41 strain serotype o101, e.coli 31a antigen - suspension for injection - unknown - inactivated bovine rotavirus vaccine + inactivated bovine coronavirus vaccine + inactivated escheri - bovine - immunological - inactivated vaccine

IBH 4/8 Formulation: Each 0.5 mL dose contains: AAF containing IBH virus, serotype 4 >0.040 mL, minimum titer AGP 1/16/mL or RT-PCR 21006 vp/0.5 mL AAF containing IBH virus, serotype 8 >0.040 mL, minimum titer AGP 1/16/mL or RT-PCR >100.6 vp/0.5 mL Emulsion for Injection (SC) Filipino - Kiingereza - FDA (Food And Drug Administration)

ibh 4/8 formulation: each 0.5 ml dose contains: aaf containing ibh virus, serotype 4 >0.040 ml, minimum titer agp 1/16/ml or rt-pcr 21006 vp/0.5 ml aaf containing ibh virus, serotype 8 >0.040 ml, minimum titer agp 1/16/ml or rt-pcr >100.6 vp/0.5 ml emulsion for injection (sc)

compania j.m., inc. - inactivated avian adenovirus vaccine (vet.) - emulsion for injection (sc) - formulation: each 0.5 ml dose contains: aaf containing ibh virus, serotype 4 >0.040 ml, minimum titer agp 1/16/ml or rt-pcr 21006 vp/0.5 ml aaf containing ibh virus, serotype 8 >0.040 ml, minimum titer agp 1/16/ml or rt-pcr >100.6 vp/0.5 ml

BOVIGEN SCOUR EMULSION FOR INJECTION FOR CATTLE Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

bovigen scour emulsion for injection for cattle

forte healthcare ltd - bovine rotavirus strain tm-91 (inactivated), bovine coronavirus strain c-197 (inactivated), escherichia coli adhesion f5 (k99) (inactivated) - emulsion for injection - unknown - inactivated bovine rotavirus vaccine + inactivated bovine coronavirus vaccine + inactivated escheri - bovine - immunological - inactivated vaccine

Suvaxyn Parvo/E Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

suvaxyn parvo/e

zoetis belgium s.a. - inactivated porcine parvovirus, strain s-80; inactivated erysipelothrix rhusiopathiae, strain b-7 (serotype 2) - emulsion for injection - 160/ >1.8 haemagglutination inhibiting antibody / relative potency - porcine parvovirus + erysipelothrix - pigs - immunological - inactivated vaccine